IOVS AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:4482-4489.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0139

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Awasthi, N.
Right arrow Articles by Wagner, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awasthi, N.
Right arrow Articles by Wagner, B. J.

Suppression of Human Lens Epithelial Cell Proliferation by Proteasome Inhibition, a Potential Defense against Posterior Capsular Opacification

Niranjan Awasthi1 and B. J. Wagner1,2

1From the Departments of Biochemistry and Molecular Biology and 2Ophthalmology, University of Medicine and Dentistry of New Jersey (UMDNJ), New Jersey Medical School, Newark, New Jersey.

PURPOSE. Posterior capsular opacification (PCO) is caused by the proliferation, migration, and epithelial–mesenchymal transition (EMT) of the remaining lens epithelial cells (LECs) after cataract surgery. Studies have shown that proteasome inhibition interferes with EMT and remodeling of the extracellular matrix. This study was conducted to investigate suppression of LEC proliferation by proteasome inhibition and its signaling pathway.

METHODS. HLE B-3 cells and human lens epithelium explants from 17- to 20-week fetal lenses were cultured and treated with TGF-ß2 (1 or 10 ng/mL), FGF-2 (20 or 50 ng/mL), HGF (10 ng/mL) and 5 or 10 µM MG132. LEC proliferation was determined using both the WST-1 reagent and proliferating cell nuclear antigen (PCNA) expression. Protein expression was observed by Western blot analysis. Transfection with p21/p27 siRNA was performed to evaluate the mechanism of the antiproliferative effect of proteasome inhibition.

RESULTS. TGF-ß2 suppressed proliferation of HLE B-3 cells, whereas FGF-2 and HGF enhanced proliferation. Proliferation suppression by TGF-ß2 was blocked by adding FGF-2 or HGF. Proteasome inhibitor (MG132) treatment strongly inhibited the proliferation of LECs, either alone or in the presence of TGF-ß2, FGF-2, or HGF. These findings were confirmed by observing PCNA expression. Similar results were obtained with primary human LECs. Expression of cell cycle regulatory proteins was determined to evaluate the mechanism of the antiproliferative activity of proteasome inhibition. MG132 caused a significant increase in p21 and p27 protein and decrease in CDK2, but no change in p53, p57, CDK4, or CDK6 protein. The antiproliferative effect of MG132 was significantly reversed in samples transfected with p21 and p27 siRNA, which reduced p21 and p27 protein expression to very low levels that remained below basal control levels, even after treatment with MG132.

CONCLUSIONS. Proteasome inhibition decreases the proliferation of LECs in the presence or absence of TGF-ß2, FGF-2, and HGF. This process is mediated in part by an increase in p21 and p27 proteins. These findings suggest that proteasome inhibitors are good candidates for blocking development of PCO.





This article has been cited by other articles:


Home page
Arch OphthalmolHome page
N. Awasthi, S. Guo, and B. J. Wagner
Posterior Capsular Opacification: A Problem Reduced but Not Yet Eradicated
Arch Ophthalmol, April 1, 2009; 127(4): 555 - 562.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
N Lois, R Dawson, J Townend, A D McKinnon, G C Smith, R v. Hof, N Van Rooijen, and J V Forrester
Effect of short-term macrophage depletion in the development of posterior capsule opacification in rodents
Br. J. Ophthalmol., November 1, 2008; 92(11): 1528 - 1533.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Awasthi, S. T. Wang-Su, and B. J. Wagner
Downregulation of MMP-2 and -9 by Proteasome Inhibition: A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular Opacification
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1998 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
N Congdon, H Fan, K Choi, W Huang, L Zhang, S Zhang, K Liu, I C Hu, Z Zheng, and D S C Lam
Impact of posterior subcapsular opacification on vision and visual function among subjects undergoing cataract surgery in rural China: Study of Cataract Outcomes and Up-Take of Services (SCOUTS) in the Caring is Hip Project, Report 5
Br. J. Ophthalmol., May 1, 2008; 92(5): 598 - 603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology